$0.01
(Market cap
$846 Mln
Revenue (TTM)
$581 Mln
P/E Ratio
--
P/B Ratio
0.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.2 %
-
ROCE
-- %
-
Industry P/E
40.45
-
EV/EBITDA
19.9
-
Debt to Equity
0.3
-
Book Value
$--
-
EPS
$-0.3
-
Face value
--
-
Shares outstanding
755,092,256
10 Years Aggregate
CFO
$-313.63 Mln
EBITDA
$-598.69 Mln
Net Profit
$-1,512.83 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Opko Health Inc (OPK)
| -11.9 | -4.3 | -8.3 | -10.5 | -13.6 | -19.7 | -19.4 |
|
BSE Sensex*
| -11.5 | -2.5 | -9.3 | -7.6 | 6.5 | 9.0 | 11.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Opko Health Inc (OPK)
| -14.3 | -2.6 | 20.8 | -74.0 | 21.8 | 168.7 | -51.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Opko Health Inc (OPK)
|
1.1 | 845.7 | 581.1 | -212.9 | -34.9 | -17 | -- | 0.7 |
| 12.9 | 3,059.3 | 3,109.7 | -204.6 | 1.5 | -- | -- | 19.0 | |
| 424.0 | 5,594.1 | 2,540.6 | 259.8 | 13.7 | 27 | 23.1 | 6.6 | |
| 107.5 | 10,398.1 | 6,066.4 | 609.2 | 18.3 | 16.7 | 17.9 | 4.2 | |
| 8.1 | 2,974.7 | 1,494.8 | 23.2 | 2.0 | 1.6 | 127.8 | 2.0 | |
| 194.7 | 2,963.8 | 1,513.9 | 123.7 | 9.9 | 11.3 | 24.1 | 2.7 | |
| 19.8 | 3,113.9 | 5,667.2 | 206.2 | 5.9 | 15.2 | 15.5 | 2.4 | |
| 22.6 | 2,868.0 | 2,246.6 | 3,082.7 | 1.9 | 0.8 | 133.9 | 3.9 | |
| 15.5 | 4,400.1 | 1,189.1 | 117.8 | 27.3 | 20.1 | 37.6 | 7.2 | |
| 178.0 | 9,901.2 | 5,274.0 | 363.4 | 9.2 | 16.2 | 27.6 | 4.2 |
Shareholding Pattern
View DetailsAbout Opko Health Inc (OPK)
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a... tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune system. This segment also engages in the development of Epstein Barr Virus vaccine; Rayaldee, a patented extended-release product for oral administration containing 30 mcg of a prohormone; OPK-88006 oral and injectable product to regulate blood glucose and reduce body weight; NGENLA, recombinant human growth hormone product developed for the long-term treatment of pediatric patients with growth hormone deficiency. The Diagnostics segment offers laboratory testing services, such as detection, diagnosis, evaluation, monitoring, and treatment of diseases, as well as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare under the BioReference brand; and 4Kscore test. OPKO Health, Inc. was founded in 2006 and is headquartered in Miami, Florida. Address: 4400 Biscayne Boulevard, Miami, FL, United States, 33137 Read more
-
Chairman & CEO
Dr. Phillip Frost Ph.D.
-
Chairman & CEO
Dr. Phillip Frost Ph.D.
-
Headquarters
Miami, FL
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Opko Health Inc (OPK)
What is the current share price of Opko Health Inc (OPK) Today?
The share price of Opko Health Inc (OPK) is $1.11 (NASDAQ) as of 13-May-2026 16:00 EDT. Opko Health Inc (OPK) has given a return of -13.58% in the last 3 years.
What is the current PB & PE ratio of Opko Health Inc (OPK)?
Since, TTM earnings of Opko Health Inc (OPK) is negative, P/E ratio is not available.
The P/B ratio of Opko Health Inc (OPK) is 0.71 times as on 12-May-2026, a 79 discount to its peers’ median range of 3.41 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-4.27
|
0.76
|
|
2024
|
-19.17
|
0.75
|
|
2023
|
-6.01
|
0.82
|
|
2022
|
-2.86
|
0.60
|
|
2021
|
-104.01
|
1.86
|
What is the 52 Week High and Low of Opko Health Inc (OPK)?
The 52-week high and low of Opko Health Inc (OPK) are Rs 1.60 and Rs 0.98 as of 14-May-2026.
What is the market cap of Opko Health Inc (OPK)?
Opko Health Inc (OPK) has a market capitalisation of $ 846 Mln as on 12-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Opko Health Inc (OPK)?
Before investing in Opko Health Inc (OPK), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.